Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.1B | 1.1B | 942.3M | 910.8M |
| Cost of revenue | 600.4M | 664.1M | 538.4M | 522.2M |
| Gross profit | 471.8M | 460.0M | 403.9M | 388.7M |
| Operating expense | ||||
| Research & development | 192.7M | 196.0M | 188.9M | 195.4M |
| Selling general and admin | 190.4M | 195.1M | 179.8M | 173.6M |
| Other operating expenses | — | — | — | — |
| Operating income | 82.2M | 61.8M | 28.1M | 11.7M |
| Non operating interest income | ||||
| Income | 13.7M | 15.8M | 15.9M | 15.3M |
| Expense | 22.9M | 25.0M | 24.4M | 23.9M |
| Other income expense | -4.4M | -4.6M | -3.2M | -19.1M |
| Pretax income | 68.6M | 48.0M | 16.4M | -16.0M |
| Tax provision | 24.0M | 11.0M | 2.1M | 820K |
| Net income | 44.6M | 37.0M | 14.2M | -16.8M |
| Basic EPS | 0.3 | 0.3 | 0.1 | -0.1 |
| Diluted EPS | 0.3 | 0.3 | 0.1 | -0.1 |
| Basic average shares | 142.9M | 144.2M | 144.4M | 144.9M |
| Diluted average shares | 145.9M | 146.5M | 145.4M | 144.9M |
| EBITDA | 128.9M | 111.0M | 76.1M | 58.9M |
| Net income from continuing op. | 44.6M | 37.0M | 14.2M | -16.8M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |